GALT$3.325.68%-0.20
Galectin Therapeutics Inc (GALT)
Date: 2026-10-30 16:00O: 3.52H: 3.54L: 3.27C: 3.32Vol: 174.7k
Galectin Therapeutics Inc stock is traded at $3.32, with a volume of 174,745. It is down -5.68% in the last 24 hours and down -14.43% over the past month. Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Previous Close:
$3.52
Open:
$3.52
24h Volume:
174,745
Relative Volume:
0.88
Market Cap:
$334.82M
Revenue:
-
Net Income/Loss:
-$26.25M
P/E Ratio:
-
EPS:
-$0.4099
Net Cash Flow:
-$20.05M
1W Performance:
+4.08%
1M Performance:
-14.43%
6M Performance:
+46.26%
1Y Performance:
-34.52%
1-Day Range:
$3.27$3.54
1-Week Range:
$3.11$3.70
52-Week Range:
$2.03$7.13
Galectin Therapeutics Inc Stock (GALT) Company Profile
Name
Galectin Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
678-620-3186Address
4960 PEACHTREE INDUSTRIAL BOULEVARD, NORCROSS, GA, USACompare GALT vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GALT Galectin Therapeutics Inc | $3.32 | $334.82M | $0 | -$26.25M | -$20.05M | -$0.4099 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Galectin Therapeutics Inc Stock (GALT) Upgrades & Downgrades
Galectin Therapeutics Inc Stock (GALT) Financials Data
Revenue
Chart is being upgraded
This chart will be back soon.
Net Income
Cash Flow
EPS
Galectin Therapeutics Inc Stock (GALT) Insider Trading
- Jamil KhurramJul 14 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $3.04
- #Shares
- 16,250
- Value ($)
- 49,400
- #Shares Total
- 16,250
- Jamil KhurramJul 14 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $5.13
- #Shares
- 16,250
- Value ($)
- 83,284
- #Shares Total
- 0
- Shlevin Harold H.Jun 29 '26Director
- Transaction
- Option Exercise
- Cost
- $1.23
- #Shares
- 22,268
- Value ($)
- 27,390
- #Shares Total
- 28,768
- Jamil KhurramJun 29 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $2.50
- #Shares
- 47,467
- Value ($)
- 118,668
- #Shares Total
- 47,467
- Jamil KhurramJun 29 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $5.04
- #Shares
- 47,467
- Value ($)
- 239,234
- #Shares Total
- 0
- Harold ShlevinJun 29 '26Director
- Transaction
- Proposed Sale
- Cost
- $5.04
- #Shares
- 22,268
- Value ($)
- 112,212
- #Shares Total
- 0
- Shlevin Harold H.Jun 29 '26Director
- Transaction
- Sale
- Cost
- $5.04
- #Shares
- 22,268
- Value ($)
- 112,231
- #Shares Total
- 6,500
- Shlevin Harold H.Jun 26 '26Director
- Transaction
- Sale
- Cost
- $5.00
- #Shares
- 7,732
- Value ($)
- 38,660
- #Shares Total
- 6,500
- Shlevin Harold H.Jun 26 '26Director
- Transaction
- Option Exercise
- Cost
- $1.23
- #Shares
- 7,732
- Value ($)
- 9,510
- #Shares Total
- 14,232
- Jamil KhurramJun 26 '26Chief Medical Officer
- Transaction
- Option Exercise
- Cost
- $2.37
- #Shares
- 4,570
- Value ($)
- 10,814
- #Shares Total
- 2,533
